Valuation: Poltreg S.A.

Market Cap 119M 30.22M 27.02M 25.02M 22.67M 42.37M 2.88B 43.02M 300M 1.51B 113M 111M 4.76B P/E 2026 *
-3.65x
P/E 2027 * -1.32x
Enterprise Value 124M 31.49M 28.16M 26.07M 23.63M 44.15M 3B 44.83M 313M 1.57B 118M 116M 4.96B EV / Sales 2026 *
155x
EV / Sales 2027 * 224x
Free-Float
67.57%
Yield 2026 *
-
Yield 2027 * -
1 week+2.81%
Current month-1.95%
1 month-5.63%
3 months-14.10%
6 months+16.86%
Current year-17.96%
1 week 19.35
Extreme 19.35
21.2
1 month 19
Extreme 19
21.7
Current year 16
Extreme 16
28.6
1 year 16
Extreme 16
29.5
3 years 16
Extreme 16
60
5 years 16
Extreme 16
73.9
10 years 16
Extreme 16
73.9
Manager TitleAgeSince
Chief Executive Officer - 2019-04-30
Chief Tech/Sci/R&D Officer - 2021-10-31
Corporate Officer/Principal - 2024-02-20
Director TitleAgeSince
Chairman - 2021-05-23
Director/Board Member 51 2021-05-20
Director/Board Member 43 2023-05-31
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+2.81%-23.28%-65.93% 30.26M
+0.88%+1.18%+40.64%+74.91% 64.69B
-0.26%+7.23%+11.14%+74.78% 54.78B
+0.47%+5.10%+8.22%+101.52% 53.49B
-2.06%+2.51%+24.07%+50.98% 45.98B
-1.79%+0.49%+19.32%+122.77% 42.94B
-1.65%+3.34%+237.56%+819.04% 40.08B
-2.26%-2.06%+15.38%+45.14% 33.52B
+0.22%-4.77%+26.59%+0.55% 23.97B
+12.10%+18.47%+55.14%+45.58% 23.67B
Average +0.56%+2.84%+41.48%+126.93% 38.31B
Weighted average by Cap. +0.12%+2.59%+45.92%+149.86%

Financials

2026 *2027 *
Net sales 800K 203K 182K 168K 153K 285K 19.36M 289K 2.02M 10.13M 762K 746K 32.04M 1M 254K 227K 210K 191K 356K 24.2M 362K 2.53M 12.66M 953K 933K 40.05M
Net income -31M -7.88M -7.04M -6.52M -5.91M -11.04M -750M -11.21M -78.3M -392M -29.53M -28.91M -1.24B -95.7M -24.32M -21.75M -20.13M -18.25M -34.1M -2.32B -34.62M -242M -1.21B -91.17M -89.25M -3.83B
Net Debt 5M 1.27M 1.14M 1.05M 953K 1.78M 121M 1.81M 12.63M 63.28M 4.76M 4.66M 200M 105M 26.68M 23.86M 22.09M 20.02M 37.41M 2.54B 37.98M 265M 1.33B 100M 97.92M 4.21B
Projected Income Statement - Annual - Poltreg S.A.
Logo Poltreg S.A.
Poltreg SA is a Poland-based company engaged primarily in biotechnology and medical research. The Company conducts research in the field of autoimmunological diseases. The Company works on a method of healing, that uses t-regulated cells (TREGs). The Firm possesses its own, patented technology to obtain T-regulated lymphocytes, that are used in the therapy. The Company works on therapy for diseases such as type one diabetes, type two diabetes, and multiple sclerosis. In its research, the Company cooperates with multiple specialists from various fields of science. The Company is developing its own research center, which is intended as a basic location for conducting future research activities.
Employees
34
Date Price Change Volume
26-10-26 PLN 20.10 0.00% 1,332
26-10-23 PLN 20.10 -2.43% 111
26-10-22 PLN 20.60 -2.83% 2,659
26-10-21 PLN 21.20 +7.61% 3,644
26-10-20 PLN 19.70 -1.01% 3,398
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
20.10PLN
Average target price
29.30PLN
Spread / Average Target
+45.77%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Poltreg S.A.